905459-27-0,
[1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) dichloride,
927706-57-8,
PEPPSI-SIPR,
(1,3-Bis(2,6-diisopropylphenyl)imidazolidene) ( 3-chloropyridyl) palladium(II) dichloride,
(1,3-Bis(2,6-diisopropylphenyl)imidazolidene) ( 3-chloropyridyl) palladium(II) dichloride,
(1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDENE) (3-CHLOROPYRIDYL) PALLADIUM(II) DICHLORIDE,
(1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene)(3-chloropyridyl)palladium(II) dichloride,
1,3-bis[2,6-di(propan-2-yl)phenyl]-2H-imidazole;3-chloropyridine;dichloropalladium,
PEPPSI(TM)-IPR,
C32H42Cl3N3Pd,
PEPPSI(TM)-IPr catalyst,
PEPPSI™-IPr catalyst,
BLDKGTGQENJFON-UHFFFAOYSA-L,
KS-00000X3A,
PEPPSI(TM)-IPr catalyst, 98%,
5071AC,
AKOS024259162,
PEPPSI™-IPr impregnated tablets,
SC10558,
AK110575,
ST2407801,
PEPPSI™-IPr, ChemDose™ tablets,
PEPPSI(TM)-IPr, ChemDose(TM) tablets, Loading: 2mumol per tablet,
(1,3-bis(2,6-diisopropylphenyl)imidazolidene)(3-chloropyridyl)palladium(ii)dichloride,
DICHLORO-[1,3-BIS(DIISOPROPYLPHENYL)IMIDAZOLYLIDENE]-(3-CHLOROPYRIDYL)PALLADIUM(II),
[1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOL-2-YLIDENE]-(3-CHLOROPYRIDYL)PALLADIUM(II) DICHLORIDE,
ChemDose™, [1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene] (3-chloropyridyl)palladium(II) dichloride impregnated tablets,
PEPPSI(TM)-SIPr catalyst,
(1,3-Bis(2,6-diisopropylphenyl)imidazolidene)(3-chloropyridyl)palladium(II) dichloride,